Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
HIT Consultant
SEPTEMBER 12, 2022
Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. to advance research and increase equitable access to clinical trials by contributing de-identified data to the LHN. A Comprehensive Multiomics Platform for the Early Detection of Cancer.
Let's personalize your content